Related Experiment Video
Updated: Jul 25, 2025

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Nasal spray (Zavegepant) for migraines: a mini-review
Muhammad Omar Larik1, Muhammad Ashhal Iftekhar1, Bilal Ulhassan Syed1
1Dow International Medical College, Dow University of Health Sciences.
Zavegepant, a new intranasal CGRP receptor antagonist, offers superior efficacy and safety for acute migraine attacks compared to oral triptans. Its nasal spray delivery is advantageous for patients experiencing nausea and vomiting.
Area of Science:
- Neurology
- Pharmacology
Background:
- Migraine represents a significant global health burden, necessitating innovative therapeutic strategies.
- Current first-line treatments like oral triptans have limitations in efficacy, safety, and patient preference.
Purpose of the Study:
- To review and compare the efficacy and safety of Zavegepant against existing migraine treatments.
- To highlight Zavegepant's potential role in current migraine treatment guidelines.
Main Methods:
- Review of recent randomized controlled trials comparing Zavegepant to placebo.
- Comparative analysis of Zavegepant with oral triptans, intranasal triptans, and other CGRP antagonists.
Main Results:
- Zavegepant demonstrated favorable results in primary endpoints and a desirable safety profile in clinical trials.
- Intranasal administration offers a key advantage for patients with nausea/vomiting during acute migraine attacks.
- Zavegepant shows superiority over existing treatments, including oral triptans.
Conclusions:
- Zavegepant is a promising novel therapy for acute migraine attacks, offering advantages in efficacy, safety, and administration route.
- Further research is needed to evaluate long-term outcomes, safety, tolerability, and drug interactions.
Related Concept Videos
Drug Delivery: Enteral Route
Anxiolytic Drugs: Benzodiazepines and Buspirone
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Upper Respiratory Drugs: Decongestants
Most decongestants are readily available over-the-counter in...

